Barrington analyst Alexander Paris raised the firm’s price target on Adtalem Global Education (ATGE) to $150 from $140 and keeps an Outperform rating on the shares after the company reported Q4 results that “significantly topped expectations” and gave initial FY26 guidance that was also “well ahead of the consensus.” Given Adtalem’s focus on nursing and healthcare, the firm believes shares deserves a premium multiple as it expects demand for healthcare professionals will continue to outpace supply “for the foreseeable future.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ATGE:
- Adtalem Global Education Amends Credit Agreement for Growth
- Adtalem Global Education reports Q4 adjusted EPS $1.66, consensus $1.53
- Adtalem Global Education sees FY26 adjusted EPS $7.60-$7.90, consensus $7.46
- Adtalem Global Education, Sallie Mae to explore new student financing model
- Is ATGE a Buy, Before Earnings?